Baxdrostat, Baxdrostat Placebo
Bax24 / D6970C00009
Phase 3 small_molecule active
Quick answer
Baxdrostat, Baxdrostat Placebo for Resistant hypertension (rHTN) defined as blood pressure that remains higher than goal levels despite the use of at least 3 anti hypertensive drugs of different classes at maximum tolerated dose, including a diuretic. is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Resistant hypertension (rHTN) defined as blood pressure that remains higher than goal levels despite the use of at least 3 anti hypertensive drugs of different classes at maximum tolerated dose, including a diuretic.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active